A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood
PHASE1
BI 1810631 trial formulation 1 (TF1) is currently used in clinical trials, ...
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
PHASE3
Beamion LUNG-3 study evaluates whether zongertinib, an oral HER2-targeted t...
Status
Recruiting
Location
ClinRé 001-022 (Premier Cancer Care and Infusion Center)
A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood
PHASE1
For Part 1 of the trial, the main objective is to assess the effect of a si...
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
PHASE1
This study is open to adults aged 18 years and older with different types o...
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
PHASE3
This study is open to adults 18 years and older with advanced or metastatic...
A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food
PHASE1
The main objective of this trial is to establish the bioequivalence of Zong...